Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy

Qingfang Li(Sichuan University), Shi H(Yunnan University)
Molecular Biomedicine
December 21, 2022
Cited by 234


Related Papers